CDK4/6 Inhibition in Cancer: The Cell Cycle Splicing Connection

Molecular and Cellular Oncology - United Kingdom
doi 10.1080/23723556.2019.1673643
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

The Rb-Cdk4/6 Signaling Pathway Is Critical in Neural Precursor Cell Cycle Regulation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

CDK4/6 Inhibition Stabilizes Disease in Patients With P16-Null Non-Small Cell Lung Cancer and Is Synergistic With mTOR Inhibition

Oncotarget
Oncology
2018English

Targeting CDK4/6 in Patients With Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2016English

CDK4/6 Inhibition as Maintenance and Combination Therapy for High Grade Serous Ovarian Cancer

Oncotarget
Oncology
2018English

Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Stromal Senescence by Prolonged CDK4/6 Inhibition Potentiates Tumor Growth

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2016English

CDK4/6 Inhibitors: Promising Opportunities Beyond Breast Cancer

Cancer Discovery
Oncology
2016English

Treating ER+ Breast Cancer With CDK4/6 Inhibitors

Cancer Discovery
Oncology
2017English

Molecular Interplay Between Cdk4 and P21 Dictates G0/G1 Cell Cycle Arrest in Prostate Cancer Cells

Cancer Letters
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy